Skip to main content
SpringerLink
Log in

Biotargets of Cancer in Current Clinical Practice

  • Book
  • © 2012

Overview

Editors:
  1. Mauro Bologna

    1. Chair of General Pathology, Department of Experimental Medicine, University of L’Aquila, L'Aquila, Italy

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Provides the latest information on the validation status of each novel biomarker
  • Covers the present debate on potential clinical use of newly discovered biochemical markers and on patentability of genetic information
  • Chapter authors are experts on the particular cancer type

Part of the book series: Current Clinical Pathology (CCPATH)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (19 chapters)

  1. Front Matter

    Pages i-xvi
    Download chapter PDF

  2. Central Nervous System Tumors

    • Paolo Aloisi, Francesco Martella, Davide Cerone, Giampiero Porzio
    Pages 1-18

  3. Head and Neck Tumours

    • Keith D. Hunter, Robert Bolt
    Pages 19-59

  4. Thyroid Cancer

    • Laura D. Locati, Angela Greco, Maria Grazia Borrello, Maria Luisa Carcangiu, Paolo Bossi, Roberta Granata et al.
    Pages 61-91

  5. Targeted Therapies for Non-small-Cell Lung Cancer

    • Giulio Metro, Lucio Crinò
    Pages 93-114

  6. Non-Hodgkin’s Lymphomas

    • Roberta Zappasodi, Massimo Di Nicola
    Pages 115-157

  7. Leukemias

    • Lia Ginaldi, Massimo De Martinis
    Pages 159-194

  8. Breast Cancer

    • Nadia Rucci, Luca Ventura, Anna Teti
    Pages 195-219

  9. Oesophago-Gastric Cancer

    • Alex M. Reece-Smith, Simon L. Parsons, Sue A. Watson
    Pages 221-244

  10. Colorectal Cancer

    • David N. Church, Rachel Susannah Midgley, David J. Kerr
    Pages 245-272

  11. Hepatocellular Carcinoma

    • Yasunori Minami, Masatoshi Kudo
    Pages 273-287

  12. Biomarkers for Prognosis and Molecularly Targeted Therapy in Renal Cell Carcinoma

    • Laura S. Schmidt
    Pages 289-324

  13. Bladder Cancer

    • Andrea Tubaro, Daniele Santini, Cosimo De Nunzio, Alice Zoccoli, Michele Iuliano
    Pages 325-354

  14. Biomarkers in Prostate Cancer

    • Mauro Bologna, Carlo Vicentini
    Pages 355-380

  15. Ovarian Cancer

    • Jessica Wangui Oribabor, Allison Ambrosio, Cesar M. Castro, Michael J. Birrer
    Pages 381-401

  16. Uterine Cancer: The Influence of Genetics and Environment on Cell Cycling Pathways in Cancer

    • Annekathryn Goodman, Leslie S. Bradford, Leslie A. Garrett
    Pages 403-417

  17. Biotargets in Sarcomas: The Past, Present, and a Look into the Future

    • Vivek Subbiah, Razelle Kurzrock
    Pages 419-438

  18. Melanoma and Other Skin Cancers

    • Kim H. T. Paraiso, Jobin K. John, Keiran S. M. Smalley
    Pages 439-468

  19. Molecular Pathology of Cancer Metastasis: Suggestions for Future Therapy

    • Adriano Angelucci, Edoardo Alesse
    Pages 469-515

  20. Current and Future Developments in Cancer Therapy Research: miRNAs as New Promising Targets or Tools

    • Marilena V. Iorio, Patrizia Casalini, Claudia Piovan, Luca Braccioli, Elda Tagliabue
    Pages 517-546
Back to top

Keywords

About this book

Biotargets of Cancer in Current Clinical Practice presents an updated and reasoned review of the current status of knowledge concerning the major cancer types with a special focus on the current biomarkers, genes involved and the potential future targets of innovative therapies. The volume includes for each major cancer type, a comprehensive although concise discussion of epidemiology, affirmed and innovative biomarkers for diagnosis, and descriptions of the relevant genes for prognosis and (individualized) therapy through biotarget-specific new molecular treatments, with the latest information on the validation status of each novel biomarker. Individual chapters are dedicated to the major cancer types, plus a special chapter on metastasis. The present debate on patentability of genetic information applied to diagnostics and therapeutics of cancer is also discussed.

Reviews

From the reviews:

“In this book on clinically significant biotargets in cancer research, every organ system is thoroughly represented with adequate overviews and precise details of the biotargets. … the book is intended specifically for clinicians in the field, including medical students, residents, pathologists, and oncologists. … This is a well-written book that attempts to provide a wide spectrum of current scientific information about the clinical management of oncologic patients based on molecular aspects. … this book achieves its objectives while remaining easy to read.” (Natalie Webster, Doody’s Review Service, October, 2012)

Editors and Affiliations

  • Chair of General Pathology, Department of Experimental Medicine, University of L’Aquila, L'Aquila, Italy

    Mauro Bologna

About the editor

Mauro Bologna, MD
University of L’Aquila, L’Aquila, Italy

Bibliographic Information

  • Book Title: Biotargets of Cancer in Current Clinical Practice

  • Editors: Mauro Bologna

  • Series Title: Current Clinical Pathology

  • DOI: https://doi.org/10.1007/978-1-61779-615-9

  • Publisher: Humana Totowa, NJ

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Science+Business Media, LLC 2012

  • Hardcover ISBN: 978-1-61779-614-2Published: 05 April 2012

  • Softcover ISBN: 978-1-4939-5946-4Published: 23 August 2016

  • eBook ISBN: 978-1-61779-615-9Published: 03 April 2012

  • Series ISSN: 2197-781X

  • Series E-ISSN: 2197-7828

  • Edition Number: 1

  • Number of Pages: XVI, 564

  • Topics: Pathology, Oncology, Laboratory Medicine

Publish with us

Policies and ethics

Back to top

Search

Navigation